While there was a trend towards more intestinal cancers in the challenged ACVR2A knock outs compared to wild type mice, this was not statistically significant, underscoring the likely overlap/synergy of TGFβ family member signaling in colon cancer (Fig. 6). The gene discussed is ACVR2A; the disease is intestinal cancer.